Literature DB >> 20010028

Psychological distress and sick leave in Swedish survivors of the 2004 tsunami: a comparison with a population sample.

Lars Wahlström1, Hans Michélsen, Abbe Schulman, Magnus Backheden.   

Abstract

Disaster studies of the effects of trauma exposure on subsequent psychological health have seldom used population comparisons. A total of 1463 tsunami survivors from Stockholm were categorized according to type of exposure, and compared on measures of General Health Questionnaire and sick leave, with a matched population-based sample of 12,045 individuals from the same region. Data from the survivor group were obtained through a postal questionnaire 14 months postdisaster. Data from the population sample were collected in the same year. In comparison to the population sample, levels of sick leave ranged from higher in multiply exposed groups to lower in the least exposed group. For psychological distress, levels in multiply and moderately exposed groups were higher, and in lower exposed groups comparable. The use of a population comparison resulted in a support of recent research showing a relative resiliency of survivors exposed during disaster to potential trauma of lesser severity.

Entities:  

Mesh:

Year:  2009        PMID: 20010028     DOI: 10.1097/NMD.0b013e3181c29a60

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  Sick leave before and after a work-place targeted terror attack.

Authors:  Marianne Bang Hansen; Mona Berthelsen; Alexander Nissen; Trond Heir
Journal:  Int Arch Occup Environ Health       Date:  2018-12-06       Impact factor: 3.015

2.  Effects of exposure to workplace terrorism on subsequent doctor certified sickness absence, and the modifying role of psychological and social work factors: a combined survey and register study.

Authors:  Mona Berthelsen; Marianne Bang Hansen; Alexander Nissen; Morten Birkeland Nielsen; Stein Knardahl; Trond Heir
Journal:  BMC Public Health       Date:  2020-03-30       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.